semaglutide medvi review for weight loss MEDVi Expands Access to Semaglutide

While this symptom is typically associated with menopause, it can also be experienced by women undergoing treatments like chemotherapy or hormonal therapy for breast cancer

The pivotal clinical trials that led to FDA approvalincluding the SUSTAIN trials for diabetes management and the STEP trials for weight managementdid not identify dry mouth as a statistically significant adverse event occurring at notably higher rates in semaglutide-treated patients compared to placebo groups

Coupling this with the monitoring capability of CGMs means you can better understand how your body responds to the medication and adjust your diet and activity levels accordingly

Timelines depend on individual factors

September 21, 2025: Litigation focus continues to shift from gastroparesis claims, which have faced challenges in demonstrating direct causation versus diabetes complications, toward vision loss cases involving non-arteritic anterior ischemic optic neuropathy (NAION)

(2008) 57:A164